Specifically, we included all the available cases of CBD (N = 28 patients) and PiD (N = 14 patients), and we selected the 33 patients with PSP who had the lowest degree of concomitant pathology. The gene discussed is MTA2; the disease is supranuclear palsy, progressive, 1.